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In vitro secretion of human chorionic gonadotrophin by bladder tumour
cells
R.K. Iles', R.T.D. Oliver', M. Kitau2, C. Walker3 and T. Chard2
'Medical Oncology Unit, Department of Urology, The London Hospital Medical College, London; 2Department of Reproductive
Physiology and Obstetrics and Gynaecology, St. Bartholomew's Hospital Medical College and the London Hospital Medical
College, London; and 3Department of Histopathology, Institute of Urology, St. Paul's Hospital, London, UK.
Summary Human chorionic gonadotrophin (hCG) and alphafetoprotein (AFP) were measured in culture
media from a panel of 29 cell lines including 9 bladder carcinomas, 5 'normal' bladder epithelia, 10 germ cell
tumours, and 5 miscellaneous tumours and 'normal' cell lines. In 7 of the 9 bladder carcinomas and 4 of the 5
'normal' bladder epithelia, the media contained hCG at levels ranging from between 34 and 3,600 IU I -. All
other cell lines, including the 10 germ cell tumour lines gave negative results for hCG. These findings indicate
that in vitro secretion of hCG is a common feature of normal and neoplastic bladder transitional epithelia,
and support the hypothesis that parts of the genito-urinary epithelium have a potential for hCG production.
The high incidence of elevated levels of human chorionic
gonadotrophin (hCG) and alphafetoprotein (AFP) in
association with testicular germ cell tumours is well-
recognised in vivo (Seppala et al., 1986), but this
phenomenon is relatively uncommon during culture of these
tumours (Andrews et al., 1980). Ectopic production of hCG
is also a well-recognised phenomenon in some non-gonadal
epithelial tumours (Braunstein et al., 1973; McManus et al.,
1976; Bellet et al., 1980). This is particularly common in
gastric (24%), hepatic (17%) and pancreatic (50%) cancers
(reviewed by Baylin & Mendelsohn, 1980; Heyderman et al.,
1985; Seppala, 1986). The incidence may be even higher with
malignant non-gonadal cells in vitro; in one such study
(Rosen et al., 1980) 19 of 32 tumour cell lines secreted hCG
(including one bladder carcinoma line). A few isolated cases
of in vivo elevated hCG levels in serum and urine in
association with bladder cancer have been reported
(Civantos & Rywlin, 1972; Kawamura et al., 1978;
Rodenburg et al., 1985; Norman et al., 1985). Very recently
measurement of hCG has been used as a marker for
monitoring metastatic bladder disease; 28 of 92 patients
demonstrated measurable levels in blood (Dexeus et al.,
1986). Immunohistochemical studies suggest that ectopic
production of hCG is relatively unusual in bladder tumours
with reports varying from 5 of 13 to 12 of 104 cases
(Rodenburg et al., 1985; Shah et al., 1986). In the present
study we have examined hCG and AFP secretion by normal
and neoplastic bladder and testicular germ cell tumours in
vitro.
Materials and methods
A total of 29 cell lines were examined in this study (Table I).
They included: 14 lines of urothelial origin (9 neoplastic (see
Table I), 5 'normal'); 10 germ cell tumours (gonadal) and 5
miscellaneous tumours and 'normal' controls. The American
Type Culture Collection (ATCC) and other lines held at the
London Hospital were grown in a medium consisting of
Leibowitz L-15 RPMI 1640 (50/50, v/v) containing 20%
heat inactivated foetal calf serum (FCS), transferrin
(4 pg ml - 1), hydrocortisone (4 ng ml - 1), insulin (4 Mg ml - 1),
and penicillin-streptomycin (1,000U ml- 1) (Gibco Ltd.,
Paisley, Scotland). Cell lines from the Institute of Urology
were grown RPMI 1640 plus 5% FCS (Gibco).
Incubation was carried out at 37°C in a mixture of 95% air
and 5% CO2. The cell lines were grown to confluence in
culture flasks (75 cm adherence area; Falcon Labware).
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Table I Cell lines used in study.
Beta-hCG AFP
Cell lines Origin Source (IU1- ) (U ml- )
(A) Urothelial Lines
Neoplastic
T24
J82
RT4
TccSUP
ScaBER
5637
RT1 12
HT1376
TccDeS
'Normar
HS0767
HU609
NB/AJ
NB/UI
NB/U-2
Tcc bladder
Tcc bladder
Tcc bladder
Tcc bladder
Scc bladder
Tcc bladder
Tcc bladder
Tcc bladder
Tcc bladder
TcE bladder
TcE bladder
TcE bladder
TcE bladder
TcE bladder
ATCC
ATCC
ATCC
ATCC
ATCC
ATCC
ATCC
Inst Ur
LH(1)
Inst Ur
Inst Ur
LH(2)
LH(2)
LH(2)
<25
56
34
34
2400
220
220
<25
3600
<25
1150
130
60
70
<10
<10
<10
<10
<10
<10
<10
<10
<10
15
<10
<10
<10
<10
(B) Germ Cell Thmours and Controls
GCTs
GCT27
1618K
HL
833K
GH
TERA II
TERA I
SuSa
WG007
PJ077
Controls
'Normal
UV/K14
Malme 3
Neoplastic
WTuO13
BrCaPE
MJ003
GCT
GCT
GCT
GCT
GCT
GCT
GCT
GCT
GCT
GCT
Inst Ur
Inst Ur
Inst Ur
Inst Ur
Inst Ur
ATCC
ATCC
Inst Ur
LH(1)
LH(1)
Skin (keratinocyte) LH(2)
Skin (fibroblast) ATCC
Wilms tumour
Breast carcinoma
Breast carcinoma
LH(1)
LH(1)
LH(1)
<25
<25
<25
<25
<25
<25
<25
<25
<25
<25
<10
<10
<10
<10
20
<10
16
18
<10
<10
<25 <10
<25 <10
<25 13
<25 <10
<25 <10
Tcc= Transitional cell carcinoma. Scc= Squamous cell carcinoma.
TcE=Transitional cell epithelia. GCT=Germ cell tumour. ATCC
=American Type Culture Collection. Inst Ur= Institute of Urology.
LH(1) = London Hospital originated by R. Iles. LH(2) = London
Hospital originated by I. Leigh & P. Purkis, Department of
Dermatology.
NB. Cell lines NB/AJ, NB/UI, NB/U2 used at Passage 3 of origin
and cell line TccDeS at pre-passage primary cultures.
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At this stage the medium (10 ml) was exchanged and the
culture continued for a further 96 h. The medium was then
harvested and, after removal of debris by centrifugation, was
stored at - 30°C until assayed. AFP was measured by
radioimmunoassay (RIA) (Chard, 1978) and hCG by RIA
directed to the beta subunit of this molecule (Norman et al.,
1985). The minimal detection limit of the latter assay is
25IU1- .
site immunometric assay (Hybritech ICON). All gave
negative results. Within the bladder cell lines there appeared
to be a general association of epithelial morphology and
high levels of beta-hCG (Table II). The occasional positive
level of AFP (Table I) was only marginally different from
the 'noise' level of the assay.
Discussion
Results
Media from 7 of the 9 bladder cancer cell lines contained
detectable levels of beta-hCG (Table IA; Figure 1). In 2 of
these (TccSUP and RT4) the concentrations were only
marginally above controls but in the remainder the levels
were substantially raised. Four of the 5 'normal' bladder
epithelial cell lines also showed levels of beta-hCG that were
markedly elevated. The media from the germ cell tumours
and other cell lines examined all gave negative results
(Figure 1). Media containing hCG levels greater than
50IU1-l were also assessed using a semi-quantitative two-
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Figure 1 Levels of hCG in the media from 9 lines of cultured
bladder tumours (see Table I), 10 germ cell tumours, 5 normal
bladder cell lines, and 10 controls (5 cell lines and 5 media
controls).
There is good evidence that hCG may be produced by
normal tissues (Yoshimoto et al., 1977, 1979a). Furthermore,
using assays of exceptional sensitivity and specificity (i.e. as
low as 0.01ngml-1), hCG can be detected in the urine of
some normal non-pregnant subjects, post-menopausal
females and women using oral contraceptive agents (Chen et
al., 1976; Armstrong et al., 1984; Huang et al., 1984).
Significant amounts of hCG (and other oncoplacental
proteins) are also found in seminal plasma (Salem et al.,
1984). These studies have led to the proposal that most
tissues are capable of synthesising hCG, and especially some
of the epithelia bordering the genito-urinary tract.
The present study confirms previous observations on the
secretion of hCG by non-gonadal malignant cells in vitro
(Rosen et al., 1980) and highlights the lack of in vitro
secretion by the testicular germ cell tumour lines in long
term culture (Andrews et al., 1980; Cotte et al., 1981). Given
the basic ability of all cells to synthesise hCG and the
derepression of this ability in many tumours (Yoshimoto,
1979b) it is not surprising that we have observed hCG
secretion by bladder tumour cells in vitro. However, the
secretion by 'normal' urothelial cell lines implies an innate
capacity for hCG secretion. This is further supported by the
apparent high frequency of this phenomenon (7 of 9 bladder
carcinoma cell lines and 4 of 5 'normal' bladder epithelia),
especially when other cell lines, including the testicular germ
cell tumours, were negative in this respect. If hCG secretion
is a characteristic feature of bladder epithelial cells in
culture, it would support the hypothesis that hCG secretion
is a characteristic of the normal and neoplastic urothelium.
The primary cell line TccDeS (beta-hCG 3,600 IU 1 1)
provides a link between the in vivo and in vitro situation. It
was isolated from the pleural effusion of a patient with
metastatic bladder cancer who had substantial levels of hCG
in both blood and pleural fluid (760 and 2,700 IU 1-
respectively.
The apparent discrepancy between the secretion of hCG
by germ cell tumours in vitro and in vivo may be a
consequence of the very different micro-environment in vivo
allowing the tumour cells to differentiate into trophoblast
(Bronson et al., 1983; Volgelzang et al., 1983; McIlhinney,
1983). At the same time, a marginal increase of AFP does
seem to be a feature of germ cell tumours in vitro (Table IB;
(Andrews et al., 1980).
We have not as yet attempted a full molecular
characterisation of the 'hCG' detected in the cell media.
Table II Bladder cancer cell lines - morphology and histology
hCG levels
Cell line Cell morphology Grade Stage (IU 1-
SCaBER Large regular epithelial cells T3 2400
5637 Small regular epithelial cells NR NR 220
RT1 12 Small regular epithelial cells I/II NR 220
RT4 Small irregular epithelial cells I/II Ti 34
J82 Mixed epithelial and fibroblastic-like cells III T3 56
TccSUP Mixed epithelial and fibroblastic-like cells IV+ T4 34
T24 Mixed epithelial and fibroblastic-like cells III NR <25
HT1376 Variable sized regular epithelial cells III T2/3 <25
TccDeS Variable sized regular epithelial cells II/IIIa T4 3600
NR =not reported. Histology survey: Hepburn & Masters, 1983; Masters et al., 1986. aInstitute of
Pathology, The London Hospital.
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Nevertheless, the fact that high levels were determined by an
assay which is specific for the beta-chain, while negative
results were obtained with a two-site assay specific for intact
hCG, strongly suggests that the material consists principally
of the beta subunit or fragments thereof. It is interesting that
of the five ATCC (1985 catalogue) cell lines listed as hCG
secretors, 4 are of placental/foetal origin (3 choriocarcinomas
and one line of SV/40 transformed normal placental cells)
and one is a cervical epidermoid carcinoma. The latter non-
embryonal tumour cell line (CaSkl) is reported to secrete the
beta subunit than intact hCG (Pattillo et al., 1977). In
a previous study, the hCG-like material found in urine and
blood from patients with germ cell tumours appeared to be
mainly intact hCG, while material from the patient with a
metastatic bladder tumour consisted principally of free beta
subunit (Norman et al., 1985). Variability of the relative
concentration of intact hormone and free subunits, together
with heterogeneous glycosylation of the protein chains, has
also been reported in studies on patients with a variety of
other tumour types (Weintraub & Rosen, 1973; Rosen &
Weintraub, 1974; Kahn et al., 1977; Yoshimoto et al.,
1979b). The degree of glycosylation affects various
biochemical characteristics and also the rate of metabolism
in vivo (Van Hall et al., 1971; Tsuruhara et al., 1972).
Independent production of subunit and intact hormone is
not surprising as there is evidence that the genes for the
alpha and beta subunits may be on different chromosomes.
Thus, the alpha chain has been cloned (Fiddes & Goodman,
1979) and tentatively assigned to chromosome 6 (Naylor et
al., 1984), whereas the beta chain, also cloned (Fiddes et al.,
1980) has been mapped to chromosome 19 (Julier et al.,
1984). Furthermore, the beta hCG 'gene' is itself very
heterogeneous consisting of a cluster of at least eight genes
arranged in tandem and inverted pairs; one of this cluster is
the gene for the beta chain of luteinising hormone (LH)
(Boorstein et al., 1982; Talmadge et al., 1983).
The significance of this genetic complexity is unclear at the
present time (Talmadge et al., 1984; Whitfield & Kourides,
1985) but may partly explain the very variable results
reported here and in the literature.
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